This country profile provides an overview of the Central African Republic’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
40%
Blinding trachoma
35%
Intestinal worms
86%
Bilharzia
94%
River blindness
66%
2.25 million
people received treatment in the Central African Republic in 2019
2.20 million
people did not receive treatment in the Central African Republic in 2019
Elephantiasis
Treatment coverage increased from 31% in 2018 to 40% in 2019.
People needing treatment
4.44m
People receiving treatment
1.78m
Blinding trachoma
Treatment coverage increased from 24% in 2018 to 35% in 2019.
People needing treatment
3.11m
People receiving treatment
1.08m
Intestinal worms
Treatment coverage increased from 35% in 2018 to 86% in 2019.
Pre-sch and school-aged children needing treatment
997k
Pre-school and school-aged children receiving treatment
857k
Bilharzia
Treatment coverage increased from 44% in 2018 to 94% in 2019.
School-aged children needing treatment
478k
School-aged children receiving treatment
448k
River blindness
Treatment coverage increased from 34% in 2018 to 66% in 2019.
People needing treatment
2.61m
People receiving treatment
1.73m
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Central African Republic.